224 results
424B3
CYDY
CytoDyn Inc.
16 Apr 24
Prospectus supplement
5:16pm
dividend yield
Equity Incentive Plan (“EIP”)
As of February 29, 2024, the Company had one active stock-based equity plan, the CytoDyn Inc. Amended … and Restated 2012 Equity Incentive Plan (the “EIP”). As of February 29, 2024 and May 31, 2023, the EIP covered a total of 56.3 million shares of common
424B3
CYDY
CytoDyn Inc.
16 Apr 24
Prospectus supplement
5:15pm
dividend yield
Equity Incentive Plan (“EIP”)
As of February 29, 2024, the Company had one active stock-based equity plan, the CytoDyn Inc. Amended … and Restated 2012 Equity Incentive Plan (the “EIP”). As of February 29, 2024 and May 31, 2023, the EIP covered a total of 56.3 million shares of common
424B3
CYDY
CytoDyn Inc.
29 Jan 24
Prospectus supplement
5:22pm
short- and long-term incentive plans in which other executive officers may participate, including an target annual bonus of 40% of his base salary … of the Company’s common stock under the Company’s Amended and Restated 2012 Equity Incentive Plan. The stock option will have an exercise price equal to 100
8-K
EX-10.1
eouigf14zvd wfb
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
8-K
y4h6scsihv8s7
29 Jan 24
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
8:40am
424B3
1ysky1p0595fnm dt
19 Jan 24
Prospectus supplement
5:15pm
8-K
EX-99.1
d4up3fvi
3 Nov 23
Regulation FD Disclosure
5:41pm
DEFA14A
qa72g9g
3 Nov 23
Additional proxy soliciting materials
5:40pm
424B3
qi8r2lfl69uumz3
24 Oct 23
Prospectus supplement
6:01am
424B3
6x7ji esjx
10 Oct 23
Prospectus supplement
6:02pm
POS AM
yjzan63s4o2422t8k
2 Oct 23
Prospectus update (post-effective amendment)
5:15pm
424B3
05mt3usqu1neqs33jjmr
11 Jul 23
Prospectus supplement
5:28pm